I remember a time, not too long ago, a simpler time, when playing with friends meant going outside and throwing a frisbee or playing basketball. Calling a relative didn’t include seeing them through a camera on a smartphone or tablet, it meant dialing their number by pressing numbers on a landline and speaking to your grandparent. All of that has since changed following the advent of modern technology. Now, I am in no way negating the benefits of technology, nor am I renouncing any of these devices, I am merely reminiscing of a time when life was less complicated.
Moving on, it’s safe to say that there are few, if any, people in the world that haven’t heard of Google (GOOGL). The Company created a search engine which has since revolutionized how we ascertain information, as well as how businesses reach out to consumers. During that time, Google (GOOGL) has been given a home in the Oxford English Dictionary, as well as expanded its operations to far more than an internet-powered encyclopedia on everything anyone could ever know. We’ve seen Google Maps (GOOGL), Google’s own smartphone, the Pixel, and countless other innovations from the gargantuan tech company.
Surprising no one, Google (GOOGL) on Tuesday announced the unveiling of a video game streaming service called Stadia which will allow users to play the game that they love without the need for purchasing wallet-emptying consoles or computers. In terms of rendering the games for user play, this work will be handled by Google’s (GOOGL) cloud platform. Per the details of the official announcement, with Stadia, YouTube watchers will be able to click “Play now” at the end of a video and their game will start within five seconds. Perhaps the craziest part about Stadia is that the “data center is the platform,” meaning that players can start at one platform and continue where they left off on any advice capable of connecting to Google (GOOGL).
Gamers can use keyboards and mice, or use a specially-designed Stadia controller that will be sold later in the year. According to Google (GOOGL), Stadia will support 4K gaming t 60fps with HDR, with plans to allow for 8K gaming in the near future. The only missing piece of Google’s (GOOGL) into the billion-dollar gaming industry is that the Company has yet to sign on game studios to build a gaming library for Stadia. Because the platform won’t require a console, it may very well only work with games designed for Stadia. Having said that, it would be unwise for Google (GOOGL) not to integrate cross-platform play into Stadia’s platform, especially given that gamers love playing with friends who may use a different console than their own.
“The power and accessibility of streaming will give billions unprecedented opportunities to play video games in the future. We are proud to partner with Google on Stadia, building on what we’ve learned with Project Stream via Assassin’s Creed Odyssey. This is only the beginning, and we can’t wait to continue collaborating closely with Google on what’s next for Stadia.”
–Yves Guillemot, Chief Executive Officer, Ubisoft
Given that Stadia was announced only a few hours ago, not much is known about the search engine’s gaming platform. One of the biggest questions on everyone’s mind is how Google (GOOGL) plans on monetizing Stadia. Google’s CEO, Sundar Pichai, said that he wants Stadia to be a “platform for everyone,” but this doesn’t necessarily mean that it will be a platform that everyone can afford. If for some bizarre reason, Stadia ends up being a free download for users, perhaps Google (GOOGL) will have a subscription-based model for access to their game library, or maybe they’ll show ads every thirty seconds of play.
Biotech Stocks To Watch In June: Cara Therapeutics (CARA) & Intellia Therapeutics (NTLA)
Among biotech companies, the competition between Cara Therapeutics Inc (CARA) and Intellia Therapeutics Inc (NTLA) has been an intriguing one. The two companies had been on the same level as far as the market cap goes during most of the year so far.
But Cara has now pulled ahead by as much as $150 million following positive data from its lead product candidate. That being said, it is also important to keep in mind that if an investor is looking at a long term investment, then the disparity in market cap between the two companies is a minor. Here’s a look at the pros and cons of Cara and Intellia.
Cara Therapeutics (CARA)
Cara Therapeutics is currently on the rise. Its lead product candidate Korsuva injection delivered highly encouraging results in its Phase 3 trial. It’s now believed that it would not be long before Cara has its first product on the market.
It is meant for the treatment of moderate-to-severe chronic kidney disease-associated pruritus. According to reports, the results were great. Another late-stage test is going to be conducted soon. The results could be announced by the end of this year. If Korsuve is approved, then it will be marketed by Fresenius Medical Care and Vifor Pharma Group.
Cara has entered joint ventures with those companies to market the product in the United States, Japan, and South Korea. An oral version of Korsuva is also in the pipeline and could prove to be another important development.
Intellia Therapeutics (NTLA)
Intellia Therapeutics (INTA) is involved in creating CRISPR gene editing therapies. It is a segment that has a lot of promise in the future. Even though the company is some years away from having anything on the market, the promise of gene editing therapy is exciting. So much so that Intellia has already found partners in big-ticket firms like Regeneron and Novartis.
Intellia is expected to file for FDA approval for the clinical study into its lead product NLTA-2001 in 2020. It is meant for the treatment of transthyretin amyloidosis, an uncommon genetic disease. Studies into the products have proven to be promising so far. The company is also working on a product to treat myeloid leukemia.
Now when it comes to choosing between Cara and Intellia, experts believe that the former could a better company. It’s already on the verge of having an approved product on the market. Intellia, on the other hand, is likely to be some years away from winning approval.
4 Security Penny Stocks To Watch
As Threats Arise, Security Stocks Take Center Stage In 2019
With the Federal Reserve’s meeting coming, the general market is bracing for anything. Meanwhile, penny stocks are continuing to climb at absurd rates. Trading penny stocks as of late has brought many investors fruitful profits and they look to continue this trend. Here are some security penny stocks to watch for the remainder of June 2019:
Security Penny Stock #1
Liberty Defense Holdings (SCAN.V)
Market Cap: $46.404M
Liberty Defense Holdings Ltd. (SCAN.V) is a security company looking to take the industry into the next century. Liberty’s HEXWAVE product is a 3-dimensional scanning device that can detect weapons and threats of any kind. The product can do this both with speed and discretion ensuring privacy for citizens.
Liberty signed a Memorandum of Understanding with the soccer team FC Bayern München to beta test HEXWAVE in their arena. They join an ever-growing list of places that have signed MOU’s to beta test Liberty’s product. This MOU expands its ability to comply with and test the market requirements for their product internationally.
“The reception to our HEXWAVE product has been fantastic and we are excited about working alongside FC Bayern Munich, a team that is a household name in both Europe and North America, […] Our ability to deploy in both indoor and outdoor settings, with covert and overt applications, sets us apart and has also been driving increasing interest from the market.”Bill Riker, CEO of Liberty
Security Penny Stock #2
Magal Security Systems (MAGS)
Market Cap: $101.371M
Magal Security Systems Ltd. (MAGS) provides security solutions both online and physical. Some services provided include identifying potential security problems, integrating new systems, and custom designs for any type of security needs.
Recently, Magal received a $5.5 million contract for its advanced perimeter intrusion detection system. The system prevents people from illegally crossing border fences and walls.
Dror Sharon, CEO of Magal, stated, “Magal is a world leader in perimeter intrusion technologies. Our growing wins of orders such as this – providing sensors for active international borders, is due to the decades of experience that we have in providing systems that have more than proven themselves in-the-field.”
Security Penny Stock #3
Rekor Systems (REKR)
Market Cap: $27.502M
Rekor Systems Inc. (REKR) is a company that has developed surveillance technology to enhance public safety, banking, and traffic management. Primarily, the company takes their advanced software, which utilizes machine learning and upgrades IP cameras to the next level. This reduces the cost when collecting highway tolls and helps manage traffic congestion.
Throughout June, Rekor Systems has been gaining recognition and application across the US. On June 3rd Rekor obtained a contract to start deploying its Mobile LBR-2 vehicle recognition systems. After this deployment on the 3rd, the LPR-2 system North Carolina law enforcement placed an order. On June 12th, Colorado highway authorities chose Rekor’s cloud system called NUMERUS to read enhance their license plate reading.
Security Penny Stock #4
BIO-key International (BKYI)
Market Cap: $18.03M
BIO-key International Inc. (BKYI) is a security technologies company that is pushing past the limits of fingerprint scanning. BIO-key provides a plethora of finger scanning products that provide security for your computer, hard drive, and the government. They have a partnership with Microsoft to develop biometric sign-in for Windows 10.
The company recently announced that a foreign defense ministry ordered more BIO-key deployment for secure access to Microsoft applications.
“We were delighted that such a capable and prestigious technology team determined that BIO-key met their security and scalability requirements and have now made follow-on investments to grow their user base. Defense Ministries are constant targets of cyber-attacks, and we are glad to help them step up authentication to the highest assurance with NIST-verified accuracy and FIPS compliance.”Jim Sullivan, SVP of BIO
Stock Price Pre Market Update – June 19, 2019
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
How Tech Is Making Life Easier?
Healthcare Penny Stocks To Watch
Is Palatin Technologies (PTN) A Penny Stock To Buy Or Sell?
Search Stock Price (StockPrice.com)
Sponsored Content4 days ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured3 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis2 months ago
Two Massive Growth Industries, One Choice for Investors
Featured5 days ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Biotechnology2 weeks ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Cannabis3 weeks ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Featured2 months ago
Opportunity Ahead for This Healthcare Stock
Stock Market Breaking News4 weeks ago
Liberty Defense (SCAN.V) Signs MOU with the Utah Attorney General for Testing of HEXWAVE